Synpromics, Solid Biosciences Join Forces to Develop Gene Therapy Options for DMD – Muscular Dystrophy News
|
Synpromics, Solid Biosciences Join Forces to Develop Gene Therapy Options for DMD
Muscular Dystrophy News Synpromics and Solid Biosciences have established a collaborative agreement to develop new potential gene therapies for the treatment of Duchenne muscular dystrophy (DMD). According to the partnership terms, Solid Biosciences will gain access to … |
